terry white chemists tramadol sr tramadol hydrochloride 150 mg oral tablet blister pack
southern cross pharma pty ltd - tramadol hydrochloride -
chemmart tramadol sr tramadol hydrochloride 200 mg oral tablet blister pack
southern cross pharma pty ltd - tramadol hydrochloride -
chemmart tramadol sr tramadol hydrochloride 150 mg oral tablet blister pack
southern cross pharma pty ltd - tramadol hydrochloride -
apo-amoxycillin/clavulanic acid 500/125 amoxicillin (as trihydrate) 500mg and clavulanic acid (as potassium clavulanate) 125mg t
southern cross pharma pty ltd - amoxicillin trihydrate,potassium clavulanate -
roxithromycin scp roxithromycin 300 mg film coated tablets blister pack
southern cross pharma pty ltd - roxithromycin, quantity: 300 mg - tablet, film coated - excipient ingredients: hyprolose; povidone; propylene glycol; purified talc; sodium starch glycollate type a; hypromellose; sodium starch glycollate type b; maize starch; magnesium stearate; colloidal anhydrous silica; poloxamer; glucose; titanium dioxide - adults: roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections caused by or likely to be caused by susceptible microorganisms: upper respiratory tract infection: acute pharyngitis, tonsillitis and sinusitis. lower respiratory tract infection: acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia. skin and skin structure infections. nongonococcal urethritis. appropriate culture and sensitivity tests should be performed when necessary to determine organism susceptibility and thus treatment suitability. therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.
roxithromycin scp roxithromycin 150 mg film coated tablets blister pack
southern cross pharma pty ltd - roxithromycin, quantity: 150 mg - tablet, film coated - excipient ingredients: povidone; sodium starch glycollate type a; glucose; purified talc; hypromellose; maize starch; sodium starch glycollate type b; propylene glycol; hyprolose; poloxamer; titanium dioxide; colloidal anhydrous silica; magnesium stearate - adults: roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections caused by or likely to be caused by susceptible microorganisms: upper respiratory tract infection: acute pharyngitis, tonsillitis and sinusitis. lower respiratory tract infection: acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia. skin and skin structure infections. nongonococcal urethritis. children: roxithromycin 150 mg tablets are indicated for the treatment of the following mild to moderately severe infections in children caused by or likely to be caused by susceptible microorganisms: acute pharyngitis. acute tonsillitis, impetigo. appropriate culture and sensitivity tests should be performed when necessary to determine organism susceptibility and thus treatment suitability. therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.
amoxyclav an 875/125 amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium clavulanate) 125 mg tablet blister pac
southern cross pharma pty ltd - amoxicillin trihydrate,potassium clavulanate -
moxiclav duo forte 875/125 amoxicillin trihydrate 875mg and clavulanic acid 125mg tablet blister pack
southern cross pharma pty ltd - amoxicillin trihydrate,potassium clavulanate -
amoxyclav an 500/125 amoxicillin (as trihydrate) 500 mg and clavulanic acid (as potassium clavulanate) 125 mg tablet blister pac
southern cross pharma pty ltd - amoxicillin trihydrate,potassium clavulanate -
moxiclav duo 500/125 amoxicillin trihydrate 500mg and clavulanic acid 125mg tablet blister pack
southern cross pharma pty ltd - amoxicillin trihydrate,potassium clavulanate -